Paediatric Haematology Doctors in Hyderabad

Low platelet counts lead to easy bruising, petechiae (small red/purple skin patches), purpura, bleeding gums, extended nosebleeds, and blood in urine, stool, or vomit. Mild instances may have no symptoms.

Consult a physician if you have chronic pallor, unexplained bruises, exhaustion, swollen lymph nodes, fever without an illness, weight loss, or a family history of blood abnormalities. Dizziness, perspiration, or a lack of appetite are all reasons to see a doctor.

If you have difficulty breathing, blood in your vomit, stool, or urine, significant bleeding that does not stop after 20-30 minutes, inconsolable sobbing, swollen/painful joints, or mental disorientation, get to the emergency room right away. Call an ambulance if you see any life-threatening indicators, such as lethargy or head trauma.

Complete blood count (CBC), blood smear, reticulocyte count, coagulation panels (PT/aPTT), bone marrow exam, and iron/vitamin levels are some of the most commonly performed tests. Identification of hereditary problems is aided by genetic testing.

Chemotherapy is the standard treatment that is frequently supplemented with immunotherapy, such as blinatumomab or CAR T cell therapy. High-risk patients may require stem cell transplantation, radiotherapy, or targeted treatments.

Treatment consists of oral iron supplements (3 mg/kg/day) given on an empty stomach with vitamin C for absorption over several months. If necessary, dietary modifications and IV iron can be used; however, gastrointestinal disturbance should be monitored.

Regular blood transfusions, iron chelation to prevent overload, and drugs such as luspatercept are all used to manage the condition. Bone marrow transplants provide a cure; folic acid supplementation and spleen excision reduce problems.

Children with hemophilia are generally treated with clotting factor replacement treatment, which involves infusing missing factors VIII or IX intravenously to prevent or control bleeding episodes. To avoid joint injury, severe instances are treated with prophylactic infusions, while acute bleeding is treated on demand. Several additional options for mild hemophilia A, such as gene therapy in specific patients or any bispecific antibody given for subcutaneous prevention.

Common procedures include central venous catheter implantation for infusions, tonsillectomies, teeth extractions, synovectomies for hemophilia joint damage, and splenectomies for severe hemolytic anemias. Bone marrow transplants address conditions such as thalassemia, whereas port insertions help in long-term therapies. To reduce the risk of bleeding during procedures, rigorous preoperative factor replacement is required.

Risks linked to factor replacement include allergic reactions, inhibitor development obstructing treatment, and transfusion-transmitted infections. Chemotherapy for leukemia causes infections, infertility, and secondary malignancies, while transfusions produce iron excess, which can harm the heart or liver. Surgical risks include severe bleeding or clots, and long-term chelation treatment may cause organ damage.

Recovery times vary in the case of chemotherapy induction for leukemia, which takes 2-3 weeks for platelets and 3-5 weeks for neutrophils. Factor infusions enable a speedy return to activities, whereas post-transplant recovery takes months with isolation. Anemia treatments improve in weeks with vitamins, but complete recovery may take months.

With contemporary treatment, childhood acute lymphoblastic leukemia (ALL) success rates exceed 90%, whereas acute myeloid leukemia (AML) success rates are approximately 70%. High-risk cases benefit from tailored therapy, which improves outcomes by 80-85%. Stem cell transplants improve relapse survival rates by 50-70%. Early reaction indicates greater success.

Regular blood tests monitor counts and organ function, while leukemia survivors require yearly check-ups for late consequences such as heart problems. Hemophilia requires lifetime prophylaxis, and iron tests are required before transfusions. Vaccinations, growth checks, and emotional assistance are essential. Family education about bleeding is essential.

Survivors face infertility, heart disease from iron excess, joint arthritis in hemophilia, and endocrine problems. Leukemia therapies produce neurocognitive impairments or secondary malignancies, while prolonged anemias delay development and puberty. Iron chelation reduces overload but requires lifetime care. Early intervention increases people’s well-being.